首页 | 本学科首页   官方微博 | 高级检索  
     


OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users
Authors:Matthijs L. Becker,Loes E. Visser,Ron H. N. van Schaik,Albert Hofman,André G. Uitterlinden,Bruno H. Ch. Stricker
Affiliation:(1) Department of Epidemiology, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands;(2) Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands;(3) Department of Clinical Chemistry, Erasmus MC, Rotterdam, The Netherlands;(4) STAR Medical Diagnostic Center, Rotterdam, The Netherlands;(5) The Netherlands Consortium on Healthy Aging, Leiden/Rotterdam, The Netherlands;(6) Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands;(7) Drug Safety Unit, Inspectorate for Health Care, The Hague, The Netherlands;
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号